EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Adalimumab‐induced leukocytoclastic vasculitis in a patient with ankylosing spondylitis: A case report

Alireza Khabbazi iD, Mehrzad Hajialilo, Sepideh Tahsini Tekantapeh iD, Sahar Farshchi Tabrizi, Alireza Salehi

Clinical Case Reports · 2024-08 · 12 (8)

DOI: 10.1002/ccr3.9244 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Case Reports, online erschienen am 07.08.2024. Verfasst von Alireza Khabbazi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Connective Tissue Diseases Research Center Tabriz University of Medical Sciences Tabriz Iran. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinical Key Message In patients receiving anti‐TNF‐α drugs for ankylosing spondylitis, monitoring purpuric and ischemic skin lesions is crucial. This case underscores the significance of identifying and addressing drug‐induced vasculitis while stressing the necessity for prompt evaluation and exploration of alternative treatment options to safeguard patient well‐being. Abstract The case discusses a 38‐year‐old female with a history of ankylosing spondylitis (AS) who presented with skin lesions, including purpuric skin lesions and ischemia of her right foot digits, after initiating treatment with adalimumab. After excluding other potential causes, such as infections and malignancies, the patient received a diagnosis of moderate‐sized vascular vasculitis associated with adalimumab use. Discontinuation of adalimumab and treatment with high dose glucocorticoids and intravenous pulse of cyclophosphamide resulted in the resolution of her ischemic lesions. This case underscores the importance of considering drug‐related side effects in patients with new skin lesions, particularly in the context of rheumatic diseases such as AS.

Schlagwörter

Stichwörter der Autor:innen

adalimumabankylosing spondylitisanti‐TNF‐α related vasculitisleukocytoclastic vasculitisnecrotizing vasculitispolyarteritis nodosa

Autor:innen und Institutionen

  • Connective Tissue Diseases Research Center Tabriz University of Medical Sciences Tabriz Iran.
  • Department of Rheumatology Student Research Committee, Tabriz University of Medical Sciences Tabriz Iran.
  • Tabriz University of Medical Science Tabriz Iran.

ORCID-Profile: Alireza Khabbazi, Sepideh Tahsini Tekantapeh

Zitieren

APA

Khabbazi, A., Hajialilo, M., Tahsini Tekantapeh, S., Farshchi Tabrizi, S., & Salehi, A. (2024). Adalimumab‐induced leukocytoclastic vasculitis in a patient with ankylosing spondylitis: A case report. Clinical Case Reports, 12(8). https://doi.org/10.1002/ccr3.9244

Vancouver

Khabbazi A, Hajialilo M, Tahsini Tekantapeh S, Farshchi Tabrizi S, Salehi A. Adalimumab‐induced leukocytoclastic vasculitis in a patient with ankylosing spondylitis: A case report. Clinical Case Reports. 2024;12(8). doi:10.1002/ccr3.9244

BibTeX
@article{Khabbazi2024,
  author = {Khabbazi, Alireza and Hajialilo, Mehrzad and Tahsini Tekantapeh, Sepideh and Farshchi Tabrizi, Sahar and Salehi, Alireza},
  title = {Adalimumab‐induced leukocytoclastic vasculitis in a patient with ankylosing spondylitis: A case report},
  journal = {Clinical Case Reports},
  year = {2024},
  volume = {12},
  number = {8},
  doi = {10.1002/ccr3.9244}
}
Kostenlos starten →